Verve Therapeutics: Q4 Earnings Snapshot

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Verve Therapeutics Inc. (VERV) on Thursday reported a loss of $41.1 million in its fourth quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 67 cents.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.

The biotechnology firm posted revenue of $1 million in the period.

For the year, the company reported a loss of $157.4 million, or $2.91 per share. Revenue was reported as $1.9 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on VERV at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up